The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication published quarterly to serve as a means for scientific information exchange in the international pharmaceutical forum. It accepts submission of original research not published or under consideration for publication anywhere else. Specific topics of interest to the journal include, but not limited to: pharmaceutics, industrial pharmacy, pharmacology, ethnopharmacology, pharmacognosy, medicinal plants, toxicology, medicinal chemistry, novel analytical methods for drug characterization, computational and modeling approaches to drug design, bio-medical experience, clinical investigation, rational drug prescribing, pharmacoeconomics, biotechnology, biopharmaceutics and physical pharmacy. Papers with didactic orientation, bulletins and subjects of exclusively local interest will not be considered for publication.
Advertisements. Advertisements in this journal are published in reliance upon the responsibility of the advertiser to comply with all legal requirements relating to the marketing and sales of products or services advertised. The publisher and the editor-in-chief are not responsible for claims made in the advertisements published in the journal. The appearance of advertisements in this publication does not constitute endorsement, implied or intended, of the product advertised or the claims made for it by the advertiser.
Manuscript Consideration
Full Disclosure. The manuscript should provide full and appropriate credit to all who contributed to the experimental data and their interpretation and discussion. Each manuscript must be accompanied by a cover letter signed by the corresponding author on behalf of all the authors that its publication has been approved by all coauthors, if any, as well as by the responsible authorities at the institute where the work has been carried out. The cover letter should explicitly state that the manuscript has not been previously published in any language anywhere (except in the form of an abstract or as part of a published lecture, review, or thesis) and that it is not under simultaneous consideration by another journal. Moreover, Iranian Journal of Pharmaceutical Research will not publish any manuscript unless the chemical structures of all compounds are fully disclosed, either by reference to prior work providing such data or by enclosure of such data in the manuscript.
Copyright Transfer. A statement transferring copyright from the authors (or their employers, if they hold the copyright) to School of Pharmacy, Shaheed Beheshti University of Medical Sciences will be required before the manuscript can be accepted for publication.
All the articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g. as offprints), as well as all translation right. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic databases, video disks, etc. without first obtaining written permission from the publisher. The use of general descriptive names, trade names, trademarks, in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
Ethics in Animal and Clinical Investigations
Investigation using experimental animals must contain a statement confirming the adherence of the research to the Principles of Laboratory Animal Care (NIH publication #85−23, revised in 1985). Investigation involving human subjects should be in accordance with the Helsinki Declaration of 1975 (revised in 2008) and be approved by the institutional ethics committee or equivalent; and this should be stated in the “Methods” section. In addition, authors should send a notary verified letter of approval from the Ethics Committee or the Institutional Review Board.
In case of any doubt about the adherence of the research to the Helsinki Declaration, it should be demonstrated that the doubtful aspects have been explicitly approved by the relevant institutional ethics committee, and the rational for the approach should be explained.
In clinical studies involving human subjects, the patients right to privacy should be considered and any form of identifying information should not be published unless this is necessary for scientific purposes and the patient give written informed consent. in this case, this should be indicated in the manuscript.
Conflict of interests
Any information regarding the potential conflict of interests related to various aspects such as financial support by commercial firms, etc… should be disclosed in manuscripts to help clarify this issue.
Peer Review
All submissions fulfilling the journal’s requirements (regarding the field, format, the English language, and scientific quality and significance) will be reviewed anonymously by three or more national and international referees expert in the field, at least two of which are out of the editorial board members (preferably one from the scientifically advanced countries). The corresponding author could also suggest potential reviewers to the journal at the time of submission. However, the editorial board reserves the right to select or refuse to use the suggested potential reviewers. For more information regarding the manuscript review process, the authors could refer to the specific link "Journal Info: Peer Review Process".
Submission
Original research works in two forms of research paper or short communication could be submitted for consideration for publication. The review articles and commentaries are only accepted by invitation. The manuscripts should be written in clear and concise English. They should be prepared in accordance with the “Uniform Requirements for Manuscripts Submission to Biomedical Journals” proclaimed by the International Committee of Medical Journal Editors (The Complete Document appears in http: //www.icmje.org). Authors are responsible for all statements made in their work. The right is reserved to incorporate any changes deemed necessary by the Editorial Board to make contributions harmonize the editorial standards of the Journal.
The prepared manuscript should be submitted online to the following addres: www.ijpr.ir. The manuscript should be in word 2003 (or later) format. The entire article should be submitted as a single file. Do not insert tabs in references. Use one hard return at the end of each reference.
For information about the structure of the articles, the authors should read the instructions bellow. It is also suggested to refer to the latest issue of the journal (available online).
Structure of Articles
Research papers, short communications, as well as review articles and commentaries (the two latter are only accepted by invitation) that address scope of the journal will be considered for publication. The Articles should include title page, abstract, keywords, introduction, experimental details, results and discussion, acknowledgement, references, tables, figures, and legends, enumerated from the title page. While there are no fixed limitations to the length of an article, authors are asked to write their manuscripts in a clear and concise manner and to include only data crucial to arriving at their final conclusions. ShortCommunications are preliminary or final reports limited to approximately 1500 words. They must be of sufficient importance and general interest to justify accelerated publication. Commentaries represent the author’s considered opinion within the scope of the journal. If the commentary criticizes an article published in the journal, the authors of the original article will be given an opportunity to reply in the same issue in which the commentary is published. Reviews are accepted by invitation only. Authors interested in preparing a commentary or review Article should provide a brief outline to the editor, requesting an invitation to submit a manuscript in one of those categories.
Title Page: This should include title, author(s) (include first name, department affiliation, and institution), running title (≤50 characters, including spaces), name and address of author to whom correspondence and reprint requests should be addressed.
Abstract: This should not be structured but should include the title, aims, methods, results, and conclusion. It should not be more than 250 words.
Keywords: For indexing purposes, each submitted article should include five to seven keywords, preferably chosen from the Medical Subject Headings (MESH).
Acknowledgment: In this section any financial support, scientific or technical assistance, gifts, etc... should be acknowledged. permission from the parties being acknowledged should be obtained.
References: The authors are responsible for the accuracy of the bibliographic information. References must be numbered consecutively in order of citation in the text. Mark reference citations in parenthesis. Personal communications, unpublished data, including manuscripts submitted but not already-accepted for publication, may also be used as a reference.
Periodical titles should be abbreviated according to the Index Medicus. Inclusive page numbers should be given for all references. Print surnames and initials of all authors. Do not use “et al”. References to web site, web pages or other electronic sources should include access date of the data. The style and punctuation of the references should conform to the following examples:
(1) Standard journal article:
Mackness MI, Mackness B, Durrington PN, Fogelman AM, Berliner J and Lusis AJ. Paraoxonase and coronary heart disease. Curr. Opin. Lipidol. (1998) 9: 319-24.
(2) Article, no author given:
Cancer in South Africa [editorial]. S. Afr. Med. J. (1994) 84: 15-16.
(3) Chapter in a book:
Phillips SJ and Whisnant JP. Hypertension and stroke. In: Laragh JH and Brenner BM. (eds.) Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. Raven Press, New York (1995) 465-78.
(4) Book, personal author(s):
Ringsven MK and Bond D. Gerontology and Leadership Skills for Nurses. 2nd ed. Delmar Publishers, New York (1996) 123-125.
(5) Book, editor(s) as author:
Norman IJ and Redfern SJ. (eds.) Mental Health Care for Elderly People. Churchill Livingstone, New York (1996) 89-92.
(6) Book, Organization as author and publisher:
Institute of Medicine (US). Looking at the Future of the Medicaid Program. The Institute, Washington (1992) 23-26.
(7) Article in electronic form:
Morse SS. Factors in the Emergence of Infectious Diseases. Emerg. Infect. Dis. [serial online] 1995 Jan-Mar [cited 1996 Jun 5], 1: [24 screens]. Available from: URL: http://www.cdc.gov/ncidod/EID/eid.htm.
(8) Conference proceedings:
Kimura J and Shibasaki H. (eds.) Recent Advances in Clinical Neurophysiology. Proceedings of the 10th International Congress of EMG and Clinical Neurophysiology, 1995 Oct 15-19, Kyoto, Japan. Elsevier, Amsterdam (1996).
(9) Conference paper:
Bengtsson S and Solheim BG. Enforcement of data Protection, Privacy and Security in Medical Informatics. In: Lun KC, Degoulet P, Piemme TE and Rienhoff O. (eds.) MEDINFO 92. Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland.
(10) Thesis:
Kaplan SJ. Posthospital Home Health Care: The Elderly’s Access and Utilization [dissertation]. St. Louis, Washington University (1995) 78-80.
Tables: The Tables should provide easier understanding and not duplicate information already included in the text or figures.
Figures: They should be included only if they augment understandability of the text. Drawings and graphs should be professionally prepared in deep-black and submitted as glossy, black-and-white clean photostats. Professionally designed computer generated graphs with a minimum of 300 DPI laser printer output is also acceptable. Each figure should have a label on the back, listing the figure number, title of manuscript, first author, and an arrow indicating the top. Illustrations should be numbered as cited in the sequential order in the text, and each should have a legend on a separate sheet. Color photographs are welcome at no extra charge.
Anti-Plagiarism Policy
Manuscripts must be devoid of any forms of plagiarism. They should also have appropriate citations to the related literature in the field.
Reprint requests
Individuals interested in any document can contact corresponding author or our web site; all IJPR documents are freely available online at http://www.ijpr.ir. Contact editorial office for large offprints.
Contact Information
For further information, please contact the Editorial Office through:
Top